CLOPIDOGREL-GA clopidogrel (as besilate) 75 mg film-coated tablet bottle pack

Land: Australien

Sprache: Englisch

Quelle: Department of Health (Therapeutic Goods Administration)

Wirkstoff:

clopidogrel besilate, Quantity: 111.86 mg (Equivalent: clopidogrel, Qty 75 mg)

Verfügbar ab:

Medis Pharma Pty Ltd

INN (Internationale Bezeichnung):

clopidogrel besilate

Darreichungsform:

Tablet, film coated

Zusammensetzung:

Excipient Ingredients: crospovidone; microcrystalline cellulose; glyceryl behenate; purified talc; lactose; titanium dioxide; iron oxide red; polyvinyl alcohol; macrogol 3350; lecithin

Verabreichungsweg:

Oral

Einheiten im Paket:

28 tablets

Verschreibungstyp:

(S4) Prescription Only Medicine

Anwendungsgebiete:

Prevention of vascular ischaemia associated with atherothrombotic events (myocardial infarction, stroke and vascular death) in patients with a history of symptomatic atherosclerotic disease. Acute coronary syndrome: Clopidogrel is indicated in combination with aspirin for patients with: Unstable angina or non-ST-elevation myocardial infarction in order to prevent early and long-term atherothrombotic events (myocardial infarction, stroke, vascular death or refractory ischaemia). Clopidogrel is indicated for treatment of acute coronary syndrome whether or not patients undergo cardiac revascularisation (surgical or PCI, with or without stent). ST-segment elevation acute myocardial infarction in order to prevent atherothrombotic events. In this population, clopidogrel has been shown to reduce the rate of death from any cause and the rate of a combined endpoint of death, re-infarction or stroke in medically treated patients eligible for thrombolytic therapy.

Produktbesonderheiten:

Visual Identification: Pink round biconvex film-coated tablet, engraved with "II" on one side; Container Type: Bottle; Container Material: HDPE; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Berechtigungsstatus:

Licence status A

Berechtigungsdatum:

2013-02-12